NCT00741832

Brief Summary

From the relationship between pathophysiology of chronic obstructive pulmonary disease (COPD), dyspnea, and dynamic hyperinflation during ventilatory increasing, the investigators hypothesize that

  1. 1.Positive expiratory pressure (PEP) breathing will reduce dyspnea more than normal breathing during exercise in mild to moderate COPD patients.
  2. 2.PEP breathing will improve dynamic hyperinflation during exercise more than normal breathing in mild to moderate COPD patients.
  3. 3.PEP breathing will improve cardiorespiratory function during exercise than normal breathing in mild to moderate COPD patients.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
11

participants targeted

Target at below P25 for not_applicable chronic-obstructive-pulmonary-disease

Timeline
Completed

Started Mar 2008

Shorter than P25 for not_applicable chronic-obstructive-pulmonary-disease

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2008

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

August 22, 2008

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 26, 2008

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2009

Completed
Last Updated

November 14, 2008

Status Verified

November 1, 2008

Enrollment Period

11 months

First QC Date

August 22, 2008

Last Update Submit

November 13, 2008

Conditions

Keywords

chronic obstructive pulmonary diseasedynamic hyperinflationdyspnearecoverypositive expiratory pressureexercise

Outcome Measures

Primary Outcomes (2)

  • Inspiratory Capacity

    at 0th, 5th, ~20th minutes of exercises

  • Borg scale

    at 0th and 20th minutes of exercises

Secondary Outcomes (10)

  • Heart Rate

    every minutes of exercise and recovery periods

  • Exercise time

    at the times when participants stop exercises

  • Recovery time

    the periods between end of symptomatic limited constance workload exercises to full recovery heart rate

  • Respiratory rate

    every minutes of exercise and recovery periods

  • Inspiratory time

    every minutes of exercise and recovery periods

  • +5 more secondary outcomes

Study Arms (2)

I

EXPERIMENTAL

Patients breath while a conical positive expiratory pressure device during exercises

Device: Conical Positive Expiratory Pressure Device (C-PEP)

C

ACTIVE COMPARATOR

Patients (normal) breath during exercise

Other: Control breathing

Interventions

Conical positive expiratory pressure device (C-PEP) in this study was designed on the principle of expiratory flow retardation. The principle occurs when exhaling through a small tube diameter, i.e. a small straw, pursed lip breathing, or positive expiratory pressure. Expiratory retardation, results from a decrease in tube diameter, creates flow resistance during exhalation. With flow resistance, the greater the flow the greater the back pressure, and the less the flow the lower the pressure. Expiratory retardation was applied in an attempt to facilitate exhalation and to relieve the air trapping. The optimal design was found to be: cone shape, proximal diameter is 2.0 cm, distal diameter is 0.6 cm, and length is 2.5 cm. Subjects will rest for 10-15 minutes until HR, BP are stabilized. They will undertake 15 min of alternating quadriceps exercise (30% 1 RM) either breathing with the C-PEP device.

I

Subjects will rest for 10-15 minutes until HR, BP are stabilized. They will undertake 15 min of alternating quadriceps exercise (30% 1 RM) either breathing normally.

C

Eligibility Criteria

AgeUp to 70 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with stable mild-to-moderate COPD (Both stages: FEV1/FVC \< 70%. Mild stage: FEV1 ≥ 80% predicted; Moderate stage: 50% ≤ FEV1 \< 80% predicted according to Global Initiative Obstructive Lung Disease (GOLD) guideline).
  • Free of exacerbations for more than 4 weeks (as defined by a change to pharmacological therapy, admission to hospital or ER or unscheduled clinic visit).
  • Good communication

You may not qualify if:

  • Older than 70 years old
  • Musculoskeletal problems that limit mobility
  • Cardiovascular disease
  • Neurological or psychiatric illness
  • Patient on long term oxygen or domiciliary noninvasive positive pressure ventilation
  • Any other comorbidities which would affect ability to undertake exercise test

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pulmonary research room of physical therapy department, Faculty of associated medical sciences, Khon Kaen university

Khon Kaen, Changwat Khon Kaen, 40002, Thailand

RECRUITING

Related Publications (1)

  • Padkao T, Boonsawat W, Jones CU. Conical-PEP is safe, reduces lung hyperinflation and contributes to improved exercise endurance in patients with COPD: a randomised cross-over trial. J Physiother. 2010;56(1):33-9. doi: 10.1016/s1836-9553(10)70052-7.

MeSH Terms

Conditions

Pulmonary Disease, Chronic ObstructiveDyspneaMotor Activity

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsRespiration DisordersSigns and Symptoms, RespiratorySigns and SymptomsBehavior

Study Officials

  • Watchara Boonsawat, Philosophy

    Department of medicine, Faculty of medicine, Khon Kaen university

    STUDY DIRECTOR
  • Tadsawiya Padkao, Bachelor

    Physical Therapy department, Faculty of Associated Medical Sciences, Khon Kaen university

    STUDY CHAIR
  • Chulee CU Jones, Philosophy

    Phusical Therapy Department, Faculty of Associated Medical Sciences, Khon Kaen university, Thailand

    STUDY DIRECTOR

Central Study Contacts

Tadsawiya Padkao, Bachelor

CONTACT

Chulee Jones, Philosophy

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Sponsor Type
OTHER

Study Record Dates

First Submitted

August 22, 2008

First Posted

August 26, 2008

Study Start

March 1, 2008

Primary Completion

February 1, 2009

Study Completion

February 1, 2009

Last Updated

November 14, 2008

Record last verified: 2008-11

Locations